Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic Dexamethasone and Gentamicin for Meniere's Disease
NCT05355610Unknown
- Sponsor
- Combined Military Hospital Quetta
- Start
- Apr 2021
- Primary completion
- Apr 2022
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Open-label, single-arm trial of gentamicin in Meniere's disease (MD), sponsored by Combined Military Hospital Quetta. Primary endpoint: Vestibular Severity Index at 3 months. Status: unknown.
02
Drugs
gentamicin
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT05355610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05355610.